An FIU team has patented a nanogel that delivers a polyol derived from linseed (flaxseed) oil that inhibits viral infections such as HIV and SARS-CoV-2. The polyol binds to the same regions on the viruses that antiviral medicines target, blocking the viruses from entering human cells. “The polyol compound shows strong potential to inhibit a broad spectrum of viral and bacterial infections,” says Arti Vashist.
“You can add this compound to existing treatments to give them broad-spectrum antimicrobial properties, and it’s non-toxic to healthy cells,” explains Vashist. “It may be formulated into pills, tablets, lozenges, aerosols and sterile solutions.” Given its source, the polyol is biodegradable, low-cost, and could be produced on a large scale. “This is green technology, easy to synthesize, affordable, stable and versatile.”
View Related Expert Profiles: Go to Source
